Home/Filings/4/0001068875-23-000135
4//SEC Filing

Mackay Todd C 4

Accession 0001068875-23-000135

CIK 0001068875other

Filed

Nov 28, 7:00 PM ET

Accepted

Nov 29, 3:33 PM ET

Size

345.9 KB

Accession

0001068875-23-000135

Insider Transaction Report

Form 4
Period: 2023-11-27
Mackay Todd C
Interim CEO HD Vest
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-11-275,9770 total
    Exercise: $21.20Exp: 2024-07-01Common Stock (5,977 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-11-2743,3330 total
    Exercise: $15.00Exp: 2028-01-04Common Stock (43,333 underlying)
  • Disposition to Issuer

    Common Stock

    2023-11-27$26.00/sh147,916$3,845,8160 total
  • Disposition to Issuer

    Common Stock

    2023-11-27$26.00/sh36,166$940,3160 total
  • Award

    Common Stock

    2023-11-27+24,92424,924 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-11-2727,6340 total
    Exercise: $25.24Exp: 2027-01-09Common Stock (27,634 underlying)
  • Award

    Common Stock

    2023-11-27+36,16636,166 total
  • Award

    Common Stock

    2023-11-27+38,04238,042 total
  • Disposition to Issuer

    Common Stock

    2023-11-27$26.00/sh38,042$989,0920 total
  • Disposition to Issuer

    Common Stock

    2023-11-27$26.00/sh24,924$648,0240 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-11-2714,4790 total
    Exercise: $22.10Exp: 2024-12-31Common Stock (14,479 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-11-2747,0140 total
    Exercise: $11.30Exp: 2027-05-21Common Stock (47,014 underlying)
Footnotes (12)
  • [F1]Pursuant to the Agreement and Plan of Merger, dated as of September 9, 2023 (as may be amended from time to time, the "Merger Agreement") by and among the Issuer, Aretec Group, Inc., a Delaware corporation ("Parent"), and C2023 Sub Corp., a Delaware corporation and a wholly-owned subsidiary of Parent ("Acquisition Sub"), effective November 27, 2023, among other things, Acquisition Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of Parent.
  • [F10]The option vested equally over a 3-year period, on each anniversary of the grant date, such that the option was fully vested on January 9, 2023.
  • [F11]The option vested equally over a 3-year period, on each anniversary of the grant date, such that the option was fully vested on May 21, 2023.
  • [F12]The option vests equally over a 3-year period, on each anniversary of the grant date, such that the option will fully vest on January 4, 2024.
  • [F2]Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), these shares of the Issuer's common stock ("Common Stock") and restricted stock units of the Issuer that vest solely on the basis of time ("RSUs") were automatically canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the reported number of shares multiplied by (ii) $26.00 (less any required tax withholdings).
  • [F3]On January 4, 2021, the reporting person was granted 23,333 performance-based restricted stock units ("PSUs"), which were eligible to vest from 0% to 200% at the end of a three-year performance period based on the Issuer's satisfaction of certain performance criteria. Pursuant to the terms of the Merger Agreement, these PSUs vested prior to the Effective Time at 155% of the target level of performance based on the Company's EBITDA and relative total shareholder return measured over the applicable performance period, as adjusted for the Merger.
  • [F4]Pursuant to the terms of the Merger Agreement, at the Effective Time, these PSUs were automatically canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of Common Stock underlying such PSU multiplied by (ii) $26.00 (less any required tax withholdings).
  • [F5]On January 3, 2022, the reporting person was granted 31,702 performance-based restricted stock units ("PSUs"), which were eligible to vest from 0% to 200% at the end of a three-year performance period based on the Issuer's satisfaction of certain performance criteria. Pursuant to the terms of the Merger Agreement, these PSUs vested prior to the Effective Time at 120% of the target level of performance based on the Company's EBITDA and relative total shareholder return measured over the applicable performance period, as adjusted for the Merger.
  • [F6]On January 3, 2023, the reporting person was granted 22,908 performance-based restricted stock units ("PSUs"), which were eligible to vest from 0% to 200% at the end of a three-year performance period based on the Issuer's satisfaction of certain performance criteria. Pursuant to the terms of the Merger Agreement, these PSUs vested prior to the Effective Time at 109% of the target level of performance based on the Company's EBITDA and relative total shareholder return measured over the applicable performance period, as adjusted for the Merger.
  • [F7]Pursuant to the terms of the Merger Agreement, at the Effective Time, these options to purchase shares of Common Stock ("Stock Options") automatically vested (if unvested) and were canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the excess, if any, of $26.00 over the per-share exercise price for such Stock Option multiplied by (ii) the total number of shares of Common Stock underlying such Stock Option, subject to any required tax withholding in accordance with the terms of the Merger Agreement.
  • [F8]The option vested according to the the following vesting schedule: 33.3% of the shares vested on the first anniversary of the grant date and approximately 16.7% vested at the end of each six (6) month period thereafter, such that the option was fully vested on July 1, 2020.
  • [F9]The option vested according to the the following vesting schedule: 33.3% of the shares vested on the first anniversary of the grant date and approximately 16.7% vested at the end of each six (6) month period thereafter, such that the option was fully vested on December 31, 2020.

Issuer

AVANTAX, INC.

CIK 0001068875

Entity typeother

Related Parties

1
  • filerCIK 0001757071

Filing Metadata

Form type
4
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 3:33 PM ET
Size
345.9 KB